CBFP
BIIB icon

Cedar Brook Financial Partners’s Biogen BIIB Stock Holding History

Cedar Brook Financial Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-585
Closed -$203K – 352
2021
Q2 		$203K Buy
+585
New +$177K 0.06% 354
2019
Q1 		– Sell
-705
Closed -$212K – 291
2018
Q4 		$212K Buy
+705
New +$225K 0.13% 218

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cedar Brook Financial Partners's BIIB Position: Q3 2021 in Review

Cedar Brook Financial Partners sold out of Biogen (BIIB) in Q3 2021, closing a stake of 585 shares — an estimated $203K sold.

Cedar Brook Financial Partners first reported a position in BIIB in Q4 2018 and held it in 2 quarters. The position peaked at $212K in Q4 2018. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Cedar Brook Financial Partners reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 585 Biogen shares in Q3 2021, an estimated $203K.
  • Cedar Brook Financial Partners first reported a position in Biogen in Q4 2018 and held it in 2 quarters.
  • Cedar Brook Financial Partners's Biogen position peaked at $212K in Q4 2018.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Cedar Brook Financial Partners's 13F filing for Q3 2021, filed 1 Nov 2021.